ARWR

ARWR

USD

Arrowhead Pharmaceuticals Inc. Common Stock

$16.740-0.430 (-2.504%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$17.170

Máximo

$17.490

Mínimo

$16.685

Volume

1.22M

Fundamentos da empresa

Capitalização de mercado

2.3B

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

1.84M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $9.57Atual $16.740Máximo $30.41

Notícias relacionadas

BusinessWire

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity

ARO-ALK7 is the first investigational RNAi therapeutic to enter clinical studies that targets a gene expressed in adipose tissue Study initiation highlights Arrowhead's leadership in the delivery of siRNA to

Ver mais
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity
BusinessWire

Arrowhead Pharmaceuticals to Participate in June 2025 Investor Conferences

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it is scheduled to participate in the following upcoming investor events: Jefferies Global Healthcare Conference – June 4-5, 2025 Type: Fireside

Ver mais
Arrowhead Pharmaceuticals to Participate in June 2025 Investor Conferences
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $80 Price Target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Arrowhead Pharma with a Buy and maintains $80 price target.

Ver mais
HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $80 Price Target

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.